Please login to the form below

Not currently logged in


This page shows the latest Bamlanivimab news and features for those working in and with pharma, biotech and healthcare.

EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19

EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19

The mAb was also evaluated in the outpatient setting in the BLAZE-4 trial, sponsored by Eli Lilly, to assess the safety and efficacy of Lilly’s neutralising antibody bamlanivimab alone ... An interim analysis demonstrated that bamlanivimab plus

Latest news

More from news
Approximately 6 fully matching, plus 17 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...